Related Experiment Video
Updated: Jul 6, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Targeted therapies for hepatocellular carcinoma
Matthew R Skelton1, Bert O'Neil
1Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Clinical Advances in Hematology & Oncology : H&O
|April 9, 2008
Summary
Hepatocellular carcinoma (HCC) is a lethal cancer resistant to chemotherapy. Recent trials show sorafenib offers a survival advantage, establishing a new standard of care for unresectable HCC.
Area of Science:
- Hepatology
- Oncology
- Medical Chemistry
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide.
- Advanced HCC has historically shown resistance to conventional cytotoxic chemotherapy, with limited survival benefits observed in numerous clinical trials over the past three decades.
- The emergence of targeted therapies marks a significant shift in HCC treatment paradigms.
Purpose of the Study:
- To review recent and ongoing therapeutic strategies for Hepatocellular Carcinoma (HCC).
- To highlight novel agents including small-molecule tyrosine kinase inhibitors and monoclonal antibodies.
- To discuss the potential of combination therapies in managing advanced HCC.
Main Methods:
- Review of recent and ongoing clinical trials and studies.
- Analysis of therapeutic agents targeting HCC, including small-molecule tyrosine kinase inhibitors and monoclonal antibodies.
- Evaluation of treatment outcomes and survival data for advanced HCC.
Main Results:
- Traditional chemotherapy has largely failed to demonstrate survival benefits in advanced HCC.
- Sorafenib has shown a survival advantage, establishing it as a new standard of care for unresectable HCC.
- Ongoing research focuses on novel targeted agents and combination therapies.
Conclusions:
- Targeted therapies, such as sorafenib, represent a breakthrough in HCC treatment.
- Further investigation into small-molecule inhibitors, monoclonal antibodies, and combination regimens is crucial.
- The landscape of HCC therapy is evolving towards more personalized and effective treatment strategies.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...